The Emergence of Community-Associated MRSA and its Association with Severe Skin and Soft Tissue Infections and Necrotizing Pneumonia: A Review of an Evolving Epidemic
Keywords:
Community-Associated MRSA (CA-MRSA), Staphylococcus aureus, Skin and Soft Tissue Infections, Necrotizing Pneumonia, Panton-Valentine Leukocidin (PVL)Abstract
Introduction: Methicillin-Resistant Staphylococcus aureus (MRSA), long considered a pathogen confined to healthcare settings, emerged as a major cause of infection in healthy individuals in the community. These Community-Associated MRSA (CA-MRSA) strains demonstrated distinct microbiological features and clinical manifestations compared to their hospital-acquired counterparts.
Literature Review: A review of the pivotal literature documents the rapid rise of a CA-MRSA epidemic, largely driven in North America by the virulent USA300 genetic clone. Epidemiological and clinical studies established a strong association between CA-MRSA and a characteristic disease spectrum, primarily consisting of severe, purulent skin and soft tissue infections (SSTIs), such as abscesses and furuncles. A less common but highly feared manifestation was a devastating, rapidly progressive necrotizing pneumonia, often occurring in young, healthy individuals. The enhanced virulence of these strains was strongly linked to the high prevalence of the cytotoxin Panton-Valentine Leukocidin (PVL), which causes destruction of immune cells and promotes tissue necrosis. This epidemiological shift required significant changes in the empirical management and treatment of common community-onset infections.
Conclusion: The body of evidence established CA-MRSA as a formidable public health threat. Its association with a unique profile of severe infections and specific virulence factors fundamentally altered the clinical and microbiological landscape, compelling clinicians to consider MRSA as a primary pathogen in the community setting.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 A.Blake-Sheehy, A. Bogard (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
